Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Assessing Frailty-Specific Treatment Effect in Cardiovascular Disease: A Systematic Review

Drugs & Aging(2024)10.1007/s40266-024-01157-2Source: DataRank Database

Assessing Frailty-Specific Treatment Effect in Cardiovascular Disease: A Systematic Review is a research paper published in Drugs & Aging (2024). On theSindex it has a DataRank of 0.221. It has been cited 3 times, with 2 citing works in its 1-hop citation network.

N/A

0.221DataRank · unranked

Scored on demand from live citation data

Open Access3 citations · 2 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.33)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 94%Citation Network 6%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

0.0128

From 1 citing papers with measurable signal

Learn more about DataRank methodology →

Top 2 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 2 citers.

Integrating frailty interventions into existing care models: a comprehensive approach to enhancing patient outcomes in chronic disease management
Frontiers in Public Health202518 citations196 referencesContributes 0.015
Frailty, polypharmacy, deprescribing and 23-hour activity: insights from a mouse model
bioRxiv (Cold Spring Harbor Laboratory)20250 citations44 referencesContributes 0.000

Authors (5)

Saran Thanapluetiwong ORCID,Kailin Xu ORCID,Darae Ko ORCID,Dae Hyun Kim ORCID,Lily Zhong ORCID

Live enrichment

PubMed:39585601 PMC:PMC11884329 OpenAlex:https://openalex.org/W4404700579

National Institute on Aging

Grant: R01AG071809

National Institute on Aging

Grant: R01AG062713

National Institute on Aging

Grant: K24AG073527

National Institute on Aging

Grant: 5T35AG038027-12

NIA NIH HHS

Grant: T35 AG038027

FWCI

0.33

Citation Percentile

0.5%

Citation Trend

2025

2026

greenLicense: https://www.springernature.com/gp/researchers/text-and-data-mining

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11884329/pdf/nihms-2058395.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s40266-024-01157-2.pdf

publisherhttps://link.springer.com/article/10.1007/s40266-024-01157-2/fulltext.html

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11884329/

Fields of Study

Frailty in Older AdultsChronic Disease Management StrategiesHeart Failure Treatment and ManagementHumansCardiovascular DiseasesFrailtyAgedRandomized Controlled Trials as TopicFrail ElderlyTreatment Outcome

MeSH Terms

FrailtyAgedCardiovascular DiseasesHumansRandomized Controlled Trials as TopicFrail ElderlyTreatment Outcome

Keywords

MedicinePsychological interventionRandomized controlled trialMEDLINESystematic reviewDiseaseMeta-analysisHazard ratioPopulationPhysical therapyIntensive care medicineGerontologyInternal medicineConfidence intervalPsychiatryEnvironmental health